nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Injection site reaction—Mycophenolate mofetil—systemic scleroderma	0.00736	0.00736	CcSEcCtD
Levorphanol—Flushing—Pentoxifylline—systemic scleroderma	0.00734	0.00734	CcSEcCtD
Levorphanol—Arrhythmia—Pentoxifylline—systemic scleroderma	0.00707	0.00707	CcSEcCtD
Levorphanol—Tension—Pentoxifylline—systemic scleroderma	0.00676	0.00676	CcSEcCtD
Levorphanol—Affect lability—Mycophenolic acid—systemic scleroderma	0.00671	0.00671	CcSEcCtD
Levorphanol—Nervousness—Pentoxifylline—systemic scleroderma	0.00669	0.00669	CcSEcCtD
Levorphanol—Muscle spasms—Pentoxifylline—systemic scleroderma	0.00662	0.00662	CcSEcCtD
Levorphanol—Hypoxia—Methotrexate—systemic scleroderma	0.00661	0.00661	CcSEcCtD
Levorphanol—Renal failure—Captopril—systemic scleroderma	0.00656	0.00656	CcSEcCtD
Levorphanol—Urinary retention—Mycophenolic acid—systemic scleroderma	0.00648	0.00648	CcSEcCtD
Levorphanol—Cardiac arrest—Mycophenolic acid—systemic scleroderma	0.00648	0.00648	CcSEcCtD
Levorphanol—Hyperkinesia—Mycophenolate mofetil—systemic scleroderma	0.00646	0.00646	CcSEcCtD
Levorphanol—Abnormal vision—Mycophenolate mofetil—systemic scleroderma	0.00646	0.00646	CcSEcCtD
Levorphanol—Mood swings—Mycophenolic acid—systemic scleroderma	0.00645	0.00645	CcSEcCtD
Levorphanol—Mental disability—Mycophenolate mofetil—systemic scleroderma	0.00643	0.00643	CcSEcCtD
Levorphanol—Agitation—Pentoxifylline—systemic scleroderma	0.00633	0.00633	CcSEcCtD
Levorphanol—Diplopia—Lisinopril—systemic scleroderma	0.00614	0.00614	CcSEcCtD
Levorphanol—Palpitations—Pentoxifylline—systemic scleroderma	0.00609	0.00609	CcSEcCtD
Levorphanol—Convulsion—Pentoxifylline—systemic scleroderma	0.00597	0.00597	CcSEcCtD
Levorphanol—Cyanosis—Methotrexate—systemic scleroderma	0.00593	0.00593	CcSEcCtD
Levorphanol—Cardiac arrest—Lisinopril—systemic scleroderma	0.00584	0.00584	CcSEcCtD
Levorphanol—Dysuria—Leflunomide—systemic scleroderma	0.00577	0.00577	CcSEcCtD
Levorphanol—Dry mouth—Pentoxifylline—systemic scleroderma	0.00573	0.00573	CcSEcCtD
Levorphanol—Amnesia—Mycophenolate mofetil—systemic scleroderma	0.00572	0.00572	CcSEcCtD
Levorphanol—Confusional state—Pentoxifylline—systemic scleroderma	0.00567	0.00567	CcSEcCtD
Levorphanol—Flushing—Captopril—systemic scleroderma	0.00556	0.00556	CcSEcCtD
Levorphanol—Shock—Pentoxifylline—systemic scleroderma	0.00553	0.00553	CcSEcCtD
Levorphanol—Dysuria—Mycophenolic acid—systemic scleroderma	0.00551	0.00551	CcSEcCtD
Levorphanol—Tachycardia—Pentoxifylline—systemic scleroderma	0.00548	0.00548	CcSEcCtD
Levorphanol—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00543	0.00543	CcSEcCtD
Levorphanol—Renal failure—Leflunomide—systemic scleroderma	0.00541	0.00541	CcSEcCtD
Levorphanol—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.00538	0.00538	CcSEcCtD
Levorphanol—Affect lability—Mycophenolate mofetil—systemic scleroderma	0.00529	0.00529	CcSEcCtD
Levorphanol—Hypotension—Pentoxifylline—systemic scleroderma	0.00525	0.00525	CcSEcCtD
Levorphanol—Renal failure—Mycophenolic acid—systemic scleroderma	0.00516	0.00516	CcSEcCtD
Levorphanol—Tension—Captopril—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Levorphanol—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.00511	0.00511	CcSEcCtD
Levorphanol—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.00511	0.00511	CcSEcCtD
Levorphanol—Mood swings—Mycophenolate mofetil—systemic scleroderma	0.00509	0.00509	CcSEcCtD
Levorphanol—Insomnia—Pentoxifylline—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Levorphanol—Nervousness—Captopril—systemic scleroderma	0.00507	0.00507	CcSEcCtD
Levorphanol—Sweating—Mycophenolic acid—systemic scleroderma	0.00503	0.00503	CcSEcCtD
Levorphanol—Dysuria—Lisinopril—systemic scleroderma	0.00496	0.00496	CcSEcCtD
Levorphanol—Apnoea—Methotrexate—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Levorphanol—Dry mouth—Mometasone—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Levorphanol—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Levorphanol—Constipation—Pentoxifylline—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Levorphanol—Bradycardia—Mycophenolic acid—systemic scleroderma	0.0048	0.0048	CcSEcCtD
Levorphanol—Arrhythmia—Azathioprine—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Levorphanol—Renal failure—Lisinopril—systemic scleroderma	0.00465	0.00465	CcSEcCtD
Levorphanol—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00463	0.00463	CcSEcCtD
Levorphanol—Palpitations—Captopril—systemic scleroderma	0.00461	0.00461	CcSEcCtD
Levorphanol—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.0046	0.0046	CcSEcCtD
Levorphanol—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Levorphanol—Sweating—Lisinopril—systemic scleroderma	0.00453	0.00453	CcSEcCtD
Levorphanol—Urticaria—Pentoxifylline—systemic scleroderma	0.00446	0.00446	CcSEcCtD
Levorphanol—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00444	0.00444	CcSEcCtD
Levorphanol—Arrhythmia—Leflunomide—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Levorphanol—Hyperkinesia—Prednisone—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Levorphanol—Dysuria—Mycophenolate mofetil—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Levorphanol—Dry mouth—Captopril—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Levorphanol—Bradycardia—Lisinopril—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Levorphanol—Confusional state—Captopril—systemic scleroderma	0.00429	0.00429	CcSEcCtD
Levorphanol—Respiratory failure—Methotrexate—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Levorphanol—Dyspepsia—Mometasone—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Levorphanol—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Levorphanol—Shock—Captopril—systemic scleroderma	0.00419	0.00419	CcSEcCtD
Levorphanol—Tachycardia—Captopril—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Levorphanol—Muscle spasms—Leflunomide—systemic scleroderma	0.00414	0.00414	CcSEcCtD
Levorphanol—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Levorphanol—Tension—Mycophenolic acid—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Levorphanol—Nervousness—Mycophenolic acid—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Levorphanol—Hypotension—Captopril—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Levorphanol—Pruritus—Pentoxifylline—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Levorphanol—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Levorphanol—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Levorphanol—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Levorphanol—Flushing—Lisinopril—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Levorphanol—Amnesia—Prednisone—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Levorphanol—Insomnia—Captopril—systemic scleroderma	0.00385	0.00385	CcSEcCtD
Levorphanol—Coma—Methotrexate—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Levorphanol—Abdominal pain—Mometasone—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Levorphanol—Palpitations—Leflunomide—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Levorphanol—Arrhythmia—Lisinopril—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Levorphanol—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Levorphanol—Agitation—Mycophenolic acid—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Levorphanol—Dyspepsia—Captopril—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Levorphanol—Lethargy—Prednisone—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Levorphanol—Dizziness—Pentoxifylline—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Levorphanol—Constipation—Captopril—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Levorphanol—Tension—Lisinopril—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Levorphanol—Palpitations—Mycophenolic acid—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Levorphanol—Nervousness—Lisinopril—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Levorphanol—Affect lability—Prednisone—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Levorphanol—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00358	0.00358	CcSEcCtD
Levorphanol—Dry mouth—Leflunomide—systemic scleroderma	0.00358	0.00358	CcSEcCtD
Levorphanol—Vomiting—Pentoxifylline—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Levorphanol—Convulsion—Mycophenolic acid—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Levorphanol—Muscle spasms—Lisinopril—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Levorphanol—Rash—Pentoxifylline—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Levorphanol—Dermatitis—Pentoxifylline—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Levorphanol—Feeling abnormal—Captopril—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Levorphanol—Gastrointestinal pain—Captopril—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Levorphanol—Hypotension—Azathioprine—systemic scleroderma	0.00347	0.00347	CcSEcCtD
Levorphanol—Cardiac arrest—Prednisone—systemic scleroderma	0.00347	0.00347	CcSEcCtD
Levorphanol—Mood swings—Prednisone—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Levorphanol—Pruritus—Mometasone—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Levorphanol—Tachycardia—Leflunomide—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Levorphanol—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00342	0.00342	CcSEcCtD
Levorphanol—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Levorphanol—Confusional state—Mycophenolic acid—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Levorphanol—Abdominal pain—Captopril—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Levorphanol—Nausea—Pentoxifylline—systemic scleroderma	0.00334	0.00334	CcSEcCtD
Levorphanol—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Levorphanol—Shock—Mycophenolic acid—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Levorphanol—Hypotension—Leflunomide—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Levorphanol—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Levorphanol—Palpitations—Lisinopril—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Levorphanol—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Levorphanol—Tension—Mycophenolate mofetil—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Levorphanol—Insomnia—Leflunomide—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Levorphanol—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Levorphanol—Hypotension—Mycophenolic acid—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Levorphanol—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Levorphanol—Lethargy—Methotrexate—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Levorphanol—Dyspepsia—Leflunomide—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Levorphanol—Vomiting—Mometasone—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Levorphanol—Dry mouth—Lisinopril—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Levorphanol—Feeling abnormal—Azathioprine—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Levorphanol—Rash—Mometasone—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Levorphanol—Dermatitis—Mometasone—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Levorphanol—Confusional state—Lisinopril—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Levorphanol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Levorphanol—Insomnia—Mycophenolic acid—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Levorphanol—Pruritus—Captopril—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Levorphanol—Constipation—Leflunomide—systemic scleroderma	0.003	0.003	CcSEcCtD
Levorphanol—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Levorphanol—Shock—Lisinopril—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Levorphanol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Levorphanol—Tachycardia—Lisinopril—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Levorphanol—Abdominal pain—Azathioprine—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Levorphanol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Levorphanol—Feeling abnormal—Leflunomide—systemic scleroderma	0.00289	0.00289	CcSEcCtD
Levorphanol—Mood swings—Methotrexate—systemic scleroderma	0.00289	0.00289	CcSEcCtD
Levorphanol—Nausea—Mometasone—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Levorphanol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Levorphanol—Constipation—Mycophenolic acid—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Levorphanol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Levorphanol—Hypotension—Lisinopril—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Levorphanol—Dizziness—Captopril—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Levorphanol—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Levorphanol—Urticaria—Leflunomide—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Levorphanol—Abdominal pain—Leflunomide—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Levorphanol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Levorphanol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Levorphanol—Insomnia—Lisinopril—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Levorphanol—Vomiting—Captopril—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Levorphanol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Levorphanol—Rash—Captopril—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Levorphanol—Dermatitis—Captopril—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Levorphanol—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Levorphanol—Dyspepsia—Lisinopril—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Levorphanol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Levorphanol—Shock—Mycophenolate mofetil—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Levorphanol—Constipation—Lisinopril—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Levorphanol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Levorphanol—Bradycardia—Prednisone—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Levorphanol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Levorphanol—Nausea—Captopril—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Levorphanol—Feeling abnormal—Lisinopril—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Levorphanol—Pruritus—Leflunomide—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Levorphanol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Levorphanol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Levorphanol—Dysuria—Methotrexate—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Levorphanol—Dizziness—Azathioprine—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Levorphanol—Urticaria—Lisinopril—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Levorphanol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Levorphanol—Abdominal pain—Lisinopril—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Levorphanol—Pruritus—Mycophenolic acid—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Levorphanol—Vomiting—Azathioprine—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Levorphanol—Rash—Azathioprine—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Levorphanol—Dermatitis—Azathioprine—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Levorphanol—Flushing—Prednisone—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Levorphanol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Levorphanol—Dizziness—Leflunomide—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Levorphanol—Renal failure—Methotrexate—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Levorphanol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Levorphanol—Arrhythmia—Prednisone—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Levorphanol—Sweating—Methotrexate—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Levorphanol—Vomiting—Leflunomide—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Levorphanol—Dizziness—Mycophenolic acid—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Levorphanol—Rash—Leflunomide—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Levorphanol—Dermatitis—Leflunomide—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Levorphanol—Nausea—Azathioprine—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Levorphanol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Levorphanol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Levorphanol—Pruritus—Lisinopril—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Levorphanol—Vomiting—Mycophenolic acid—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Levorphanol—Rash—Mycophenolic acid—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Levorphanol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Levorphanol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Levorphanol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Levorphanol—Nausea—Leflunomide—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Levorphanol—Visual impairment—Methotrexate—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Levorphanol—Agitation—Prednisone—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Levorphanol—Dizziness—Lisinopril—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Levorphanol—Nausea—Mycophenolic acid—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Levorphanol—Vomiting—Lisinopril—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Levorphanol—Rash—Lisinopril—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Levorphanol—Convulsion—Prednisone—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Levorphanol—Dermatitis—Lisinopril—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Levorphanol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Levorphanol—Nausea—Lisinopril—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Levorphanol—Shock—Prednisone—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Levorphanol—Tachycardia—Prednisone—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Levorphanol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Levorphanol—Hyperhidrosis—Prednisone—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Levorphanol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Levorphanol—Rash—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Levorphanol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Levorphanol—Insomnia—Prednisone—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Levorphanol—Convulsion—Methotrexate—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Levorphanol—Dyspepsia—Prednisone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Levorphanol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Levorphanol—Constipation—Prednisone—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Levorphanol—Confusional state—Methotrexate—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Levorphanol—Feeling abnormal—Prednisone—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Levorphanol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Levorphanol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Levorphanol—Urticaria—Prednisone—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Levorphanol—Abdominal pain—Prednisone—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Levorphanol—Hypotension—Methotrexate—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Levorphanol—Insomnia—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Levorphanol—Dyspepsia—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Levorphanol—Pruritus—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Levorphanol—Feeling abnormal—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Levorphanol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Levorphanol—Urticaria—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Levorphanol—Dizziness—Prednisone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Levorphanol—Abdominal pain—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Levorphanol—Vomiting—Prednisone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Levorphanol—Rash—Prednisone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Levorphanol—Dermatitis—Prednisone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Levorphanol—Nausea—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Levorphanol—Pruritus—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Levorphanol—Dizziness—Methotrexate—systemic scleroderma	0.00099	0.00099	CcSEcCtD
Levorphanol—Vomiting—Methotrexate—systemic scleroderma	0.000952	0.000952	CcSEcCtD
Levorphanol—Rash—Methotrexate—systemic scleroderma	0.000944	0.000944	CcSEcCtD
Levorphanol—Dermatitis—Methotrexate—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Levorphanol—Nausea—Methotrexate—systemic scleroderma	0.000889	0.000889	CcSEcCtD
